Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6543955 | 1.00 | CYP3A4 (0.39) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL31589 | 1.00 | CYP3A4 (0.39) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL10324073 | 1.00 | CYP3A4 (0.39) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL30277 | 1.00 | CYP3A4 (0.39) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL15978095 | 0.91 | CYP3A4 (0.37) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL14067502 | 0.87 | CYP3A4 (0.41) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL9309105 | 0.87 | CYP3A4 (0.41) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL9308091 | 0.87 | CYP3A4 (0.41) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL22088075 | 0.87 | CYP3A4 (0.33) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL9701371 | 0.85 | CYP3A4 (0.39) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462502-A | Tenapanol Process for the preparation of intermediates | 杭州善礼生物医药科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | claimed |
| CN-108779042-B | Ruthenium and osmium monocarbonyl catalysts | 乌迪内大学 | 2022-07-19 | — | — | CN | claimed |
| US-20220168720-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2022-06-02 | — | — | US | claimed |
| CN-108779041-B | Ruthenium and osmium dicarbonyl catalysts | 乌迪内大学 | 2022-05-13 | — | — | CN | claimed |
| CN-111718250-B | Method for preparing R-citronellal | 万华化学集团股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| EP-3411346-B1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2021-04-28 | — | — | EP | claimed |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2021-04-15 | — | — | US | claimed |
| EP-3411347-B1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2021-03-31 | — | — | EP | claimed |
| US-20190030522-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2019-01-31 | — | — | US | claimed |
| EP-3411347-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | Universita' Degli Studi di Udine (IT) | 2018-12-12 | — | — | EP | claimed |
| EP-3411346-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | Universita' Degli Studi di Udine (IT) | 2018-12-12 | — | — | EP | claimed |
| WO-2017134618-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | claimed |
| WO-2017134620-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | claimed |
| EP-2095875-B1 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2014-10-01 | — | — | EP | claimed |
| EP-0631571-B1 | PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES | DU PONT (US) | 1997-06-04 | — | — | EP | claimed |
| US-5426223-A | Hydrogenation of n-acyl hydrazones in presence of catalyst comprising complex pf transition metal bonded to phosphine ligands | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-06-20 | — | — | US | claimed |
| US-5250731-A | Asymmetric hydrogenation of N-acylhydrazones to N-acylhydrazines in presence of chiral phospholane complex | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-10-05 | — | — | US | claimed |
| WO-1993019040-A1 | PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-30 | — | — | WO | claimed |
| EP-4330229-B1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2025-12-17 | — | — | EP | disclosed |
| CN-119462502-A | Tenapanol Process for the preparation of intermediates | 杭州善礼生物医药科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12129249-B2 | Method for producing optically active compound | DAY ONE BIOPHARMACEUTICALS, INC. (US) | 2024-10-29 | — | — | US | disclosed |
| EP-4406609-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | Day One Biopharmaceuticals, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| EP-3632441-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | DAY ONE BIOPHARMACEUTICALS INC (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-07-11 | — | — | US | disclosed |
| CN-117447464-A | Method for producing optically active compound | 首日生物制药公司 | 2024-01-26 | — | — | CN | disclosed |
| US-20230381763-A1 | PROPYLENE HYDROFORMYLATION PROCESSES USING BISPHOSPHINE LIGANDS AS CATALYSTS | EASTMAN CHEMICAL COMPANY (US) | 2023-11-30 | — | — | US | disclosed |
| US-11819837-B2 | Monocarbonyl ruthenium and osmium catalysts | UNIVERSITA DEGLI STUDI DI (IT) | 2023-11-21 | — | — | US | disclosed |
| CN-111032047-B | Method for producing optically active compound | 多特疗法-1公司 | 2023-10-27 | — | — | CN | disclosed |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | disclosed |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | disclosed |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | disclosed |
| CN-116209651-A | Propylene hydroformylation process using a bisphosphine ligand as catalyst | 伊士曼化工公司 | 2023-06-02 | — | — | CN | disclosed |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2023-05-11 | — | — | US | disclosed |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2023-05-11 | — | — | US | disclosed |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2023-05-11 | — | — | US | disclosed |
| CN-113321669-B | Sulfimide metal salt, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2023-03-24 | — | — | CN | disclosed |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | Universita' Delgi Studi Di Udine (IT) | 2023-02-14 | — | — | US | disclosed |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | Universita' Delgi Studi Di Udine (IT) | 2023-02-14 | — | — | US | disclosed |
| CN-108779042-B | Ruthenium and osmium monocarbonyl catalysts | 乌迪内大学 | 2022-07-19 | — | — | CN | disclosed |
| CN-114716289-A | Preparation method of chiral benzyl alcohol derivative | 华中师范大学 | 2022-07-08 | — | — | CN | disclosed |
| US-20220168720-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2022-06-02 | — | — | US | disclosed |
| US-20220168720-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2022-06-02 | — | — | US | disclosed |
| CN-113087742-B | Phosphine chiral center containing compound, organic transition metal complex and preparation method thereof | 中国科学技术大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-108779041-B | Ruthenium and osmium dicarbonyl catalysts | 乌迪内大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-111718250-B | Method for preparing R-citronellal | 万华化学集团股份有限公司 | 2022-04-22 | — | — | CN | disclosed |
| WO-2022072185-A1 | PROPYLENE HYDROFORMYLATION PROCESSES USING BISPHOSPHINE LIGANDS AS CATALYSTS | EASTMAN CHEMICAL COMPANY (US) | 2022-04-07 | — | — | WO | disclosed |
| US-11278876-B2 | Monocarbonyl ruthenium and osmium catalysts | Universtia Degli Studi Di Udine (IT) | 2022-03-22 | — | — | US | disclosed |
| US-20210347769-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | DAY ONE BIOPHARMACEUTICALS, INC. | 2021-11-11 | — | — | US | disclosed |
| EP-3411346-B1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2021-04-28 | — | — | EP | disclosed |
| US-10988469-B2 | Method for producing optically active compound | DOT THERAPEUTICS-1, INC. (US) | 2021-04-27 | — | — | US | disclosed |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2021-04-15 | — | — | US | disclosed |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2021-04-15 | — | — | US | disclosed |
| EP-3411347-B1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2021-03-31 | — | — | EP | disclosed |
| US-20200317659-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | DAY ONE BIOPHARMACEUTICALS, INC. | 2020-10-08 | — | — | US | disclosed |
| EP-3632441-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | Millennium Pharmaceuticals, Inc. (US) | 2020-04-08 | — | — | EP | disclosed |
| US-20190030522-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2019-01-31 | — | — | US | disclosed |
| US-20190030522-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2019-01-31 | — | — | US | disclosed |
| EP-3411346-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | Universita' Degli Studi di Udine (IT) | 2018-12-12 | — | — | EP | disclosed |
| US-9802887-B2 | Process for the preparation of intermediates useful for the manufacture NEP inhibitors | NOVARTIS AG (CH) | 2017-10-31 | — | — | US | disclosed |
| WO-2017134618-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017134620-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017134620-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | disclosed |
| EP-2609071-B1 | NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE OF NEP INHIBITORS | NOVARTIS AG (CH) | 2016-09-21 | — | — | EP | disclosed |
| EP-2245009-B1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 5-BIPHENYL-4-YL-2-METHYLPENTANOIC ACID DERIVATIVES | NOVARTIS AG (CH) | 2016-08-10 | — | — | EP | disclosed |
| US-9403766-B2 | Intermediates for producing NEP inhibitors or prodrugs thereof | NOVARTIS AG (CH) | 2016-08-02 | — | — | US | disclosed |
| US-20160060217-A1 | Processes | HOOK DAVID (CH) | 2016-03-03 | — | — | US | disclosed |
| WO-2016029216-A2 | METHOD FOR PRODUCING AMIDINE DERIVATIVES | BIOCRYST PHARMACEUTICALS, INC. (US) | 2016-02-25 | — | — | WO | disclosed |
| US-9227934-B2 | Processes for producing NEP inhibitors or prodrugs thereof | NOVARTIS AG (CH) | 2016-01-05 | — | — | US | disclosed |
| US-20150274650-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE NEP INHIBITORS | HOOK DAVID (CH) | 2015-10-01 | — | — | US | disclosed |
| US-20150246881-A1 | Processes | NOVARTIS AG (CH) | 2015-09-03 | — | — | US | disclosed |
| US-9085529-B2 | Process for the preparation of intermediates useful for the manufacture NEP inhibitors | NOVARTIS AG (CH) | 2015-07-21 | — | — | US | disclosed |
| US-9061973-B2 | Processes for producing NEP inhibitors or prodrugs thereof | NOVARTIS PHARMACEUTICALS CORPORATION (US) | 2015-06-23 | — | — | US | disclosed |
| EP-2095875-B1 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2014-10-01 | — | — | EP | disclosed |
| US-20140243546-A1 | Processes | NOVARTIS AG (CH) | 2014-08-28 | — | — | US | disclosed |
| US-8580974-B2 | Processes | NOVARTIS AG (CH) | 2013-11-12 | — | — | US | disclosed |
| EP-2609071-A1 | NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE NEP INHIBITORS | Novartis AG (CH) | 2013-07-03 | — | — | EP | disclosed |
| US-20130158275-A1 | NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE NEP INHIBITORS | NOVARTIS AG (CH) | 2013-06-20 | — | — | US | disclosed |
| US-8410320-B2 | Method for synthesis of secondary alcohols | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-04-02 | — | — | US | disclosed |
| US-20120142934-A1 | METHOD FOR SYNTHESIS OF SECONDARY ALCOHOLS | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-06-07 | — | — | US | disclosed |
| WO-2012025502-A1 | NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE NEP INHIBITORS | NOVARTIS AG (CH) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011033022-A2 | OSMIUM COMPLEXES USABLE AS CATALYSTS FOR THE REDUCTION OF CARBONYL COMPOUNDS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2011-03-24 | — | — | WO | disclosed |
| US-20110046397-A1 | NEW PROCESSES | NOVARTIS PHARMACEUTICALS CORPORATION | 2011-02-24 | — | — | US | disclosed |
| EP-2245009-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 5-BIPHENYL-4-YL-2-METHYLPENTANOIC ACID DERIVATIVES | Novartis AG (CH) | 2010-11-03 | — | — | EP | disclosed |
| WO-2010048138-A1 | SYNTHESIS OF INTERMEDIATES USEFUL FOR THE PRODUCTION OF CERTAIN CGRP INHIBITORS AND INTERMEDIATES USED IN SUCH SYNTHESIS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-29 | — | — | WO | disclosed |
| US-20090299093-A1 | Preparation of Gamma-Amino Acids Having Affinity for The Alpha-2-Delta Protein | PFIZER INC. | 2009-12-03 | — | — | US | disclosed |
| US-20090247743-A1 | PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | PFIZER INC | 2009-10-01 | — | — | US | disclosed |
| WO-2009090251-A2 | NEW PROCESSES | NOVARTIS AG (CH) | 2009-07-23 | — | — | WO | disclosed |
| EP-1414783-B1 | METHOD FOR THE PRODUCTION OF AMINES BY REDUCTIVE AMINATION OF CARBONYL COMPOUNDS UNDER TRANSFER-HYDROGENATION CONDITIONS | EVONIK DEGUSSA GMBH (DE) | 2009-07-15 | — | — | EP | disclosed |
| EP-2017259-A2 | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein | Pfizer Products Inc. (US) | 2009-01-21 | — | — | EP | disclosed |
| WO-2008134326-A1 | NOVEL ALDEHYDE COMPOSITION | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| EP-1973867-A1 | PREPARATION OF GAMMA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | Pfizer Products Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| US-20080194841-A1 | Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein | PFIZER INC. | 2008-08-14 | — | — | US | disclosed |
| EP-1863780-A1 | PREPARATION OF OPTICALLY PURE BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | Pharmacia & Upjohn Company LLC (US) | 2007-12-12 | — | — | EP | disclosed |
| WO-2007072159-A1 | PREPARATION OF GAMMA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | PFIZER PRODUCTS INC. (US) | 2007-06-28 | — | — | WO | disclosed |
| US-20070141684-A1 | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein | PFIZER INC | 2007-06-21 | — | — | US | disclosed |
| US-7230134-B2 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | disclosed |
| EP-1768952-A2 | PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | Warner-Lambert Company LLC (US) | 2007-04-04 | — | — | EP | disclosed |
| WO-2006100568-A1 | PREPARATION OF OPTICALLY PURE BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006100606-A2 | PREPARATION OF BETA-AMINO ACID PRECURSORS VIA INDIUM (III) MEDIATED MARKOVNIKOV ADDITION AND KNOEVENAGEL CONDENSATION | WARNER-LAMBERT COMPANY LLC (US) | 2006-09-28 | — | — | WO | disclosed |
| US-7015320-B2 | Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-03-21 | — | — | US | disclosed |
| WO-2006008612-A2 | PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | WARNER-LAMBERT COMPANY LLC (US) | 2006-01-26 | — | — | WO | disclosed |
| EP-1199301-B1 | Olefination process to itaconate and succinate derivatives | PFIZER LTD (GB) | 2005-06-08 | — | — | EP | disclosed |
| US-20040267051-A1 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | EVONIK DEGUSSA GMBH (DE) | 2004-12-30 | — | — | US | disclosed |
| US-6750363-B2 | Olefination process to itaconate and succinate derivatives | PFIZER, INC. | 2004-06-15 | — | — | US | disclosed |
| EP-1414783-A1 | METHOD FOR THE PRODUCTION OF AMINES BY REDUCTIVE AMINATION OF CARBONYL COMPOUNDS UNDER TRANSFER-HYDROGENATION CONDITIONS | Degussa AG (DE) | 2004-05-06 | — | — | EP | disclosed |
| US-20040010139-A1 | Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams | BRISTOL-MYERS SQUIBB COMPANY | 2004-01-15 | — | — | US | disclosed |
| WO-2003014061-A1 | METHOD FOR THE PRODUCTION OF AMINES BY REDUCTIVE AMINATION OF CARBONYL COMPOUNDS UNDER TRANSFER-HYDROGENATION CONDITIONS | DEGUSSA AG (DE) | 2003-02-20 | — | — | WO | disclosed |
| US-20020188121-A1 | Novel olefination process to itaconate and succinate derivatives | DERRICK ANDREW MICHAEL (GB) | 2002-12-12 | — | — | US | disclosed |
| US-6452041-B1 | REACTING ALDEHYDE OF FORMULA RCHO, OR A PROTECTED DERIVATIVE THEREOF SUCH AS A HEMIACETAL OR ADDUCT THEREOF SUCH AS A BISULPHITE, WITH A PHOSPHORUS COMPOUND TO OBTAIN SUCCINATE OR ITACONATE DERIVATIVE | PFIZER INC. | 2002-09-17 | — | — | US | disclosed |
| US-20020058832-A1 | Novel olefination process to itaconate and succinate derivatives | PFIZER INC. | 2002-05-16 | — | — | US | disclosed |
| EP-1199301-A1 | Olefination process to itaconate and succinate derivatives | Pfizer Limited (GB) | 2002-04-24 | — | — | EP | disclosed |
| US-6218559-B1 | REACTION PRODUCTS OF AN IRIDIUM(III) SALT OR A HYDRATE THEREOF, A DIPHOSPHINE HAVING SECONDARY PHOSPHINE GROUPS AND A METAL OR AMMONIUM CHLORIDE, BROMIDE OR IODIDE | NOVARITIS CORPORATION | 2001-04-17 | — | — | US | disclosed |
| EP-0741738-B1 | HYDROGENATION CATALYST, PROCESS FOR THE PREPARATION THEREOF AND HYDROGENATION PROCESS | NOVARTIS AG (CH) | 1999-10-13 | — | — | EP | disclosed |
| US-5912375-A | Hydrogenation catalyst, process for the preparation thereof and hydrogenation process | NOVARTIS CORPORATION (US) | 1999-06-15 | — | — | US | disclosed |
| EP-0631571-B1 | PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES | DU PONT (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0741738-A1 | HYDROGENATION CATALYST, PROCESS FOR THE PREPARATION THEREOF AND HYDROGENATION PROCESS | Novartis AG (CH) | 1996-11-13 | — | — | EP | disclosed |
| US-5543571-A | Preparation of optically active hydrazines and amines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-08-06 | — | — | US | disclosed |
| WO-1995021176-A1 | HYDROGENATION CATALYST, PROCESS FOR THE PREPARATION THEREOF AND HYDROGENATION PROCESS | CIBA-GEIGY AG (CH) | 1995-08-10 | — | — | WO | disclosed |
| US-5426223-A | Hydrogenation of n-acyl hydrazones in presence of catalyst comprising complex pf transition metal bonded to phosphine ligands | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-06-20 | — | — | US | disclosed |
| EP-0631571-A1 | PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES. | DU PONT (US) | 1995-01-04 | — | — | EP | disclosed |
| US-5250731-A | Asymmetric hydrogenation of N-acylhydrazones to N-acylhydrazines in presence of chiral phospholane complex | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-10-05 | — | — | US | disclosed |
| WO-1993019040-A1 | PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-30 | — | — | WO | disclosed |
| WO-1993019040-A1 | PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (28 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267051-A1 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | HNMT, AADAT, ADH5 | CYP3A4 485/4885TDP1 4457/4885TAAR1 319/4885 |
| US-20160060217-A1 | Processes | MME, NAT1, AGTR1 | CYP3A4 528/4885TDP1 1039/4885TAAR1 265/4885 |
| US-20110046397-A1 | NEW PROCESSES | MME, REN, AGTR1 | CYP3A4 550/4885TDP1 1615/4885TAAR1 263/4885 |
| US-20020188121-A1 | Novel olefination process to itaconate and succinate derivatives | HOGA1, OGDH, HADHA | CYP3A4 264/4885TDP1 3114/4885TAAR1 4471/4885 |
| US-20130158275-A1 | NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE NEP INHIBITORS | MME, DNPEP, REN | CYP3A4 213/4885TDP1 1410/4885TAAR1 906/4885 |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | OTC, ODC1, CBR3 | CYP3A4 2997/4885TDP1 908/4885TAAR1 1056/4885 |
| US-20230381763-A1 | PROPYLENE HYDROFORMYLATION PROCESSES USING BISPHOSPHINE LIGANDS AS CATALYSTS | NUDT1, BPGM, PPIP5K2 | CYP3A4 449/4885TDP1 3640/4885TAAR1 3004/4885 |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, CBR3, IDH2 | CYP3A4 2612/4885TDP1 3573/4885TAAR1 663/4885 |
| US-10988469-B2 | Method for producing optically active compound | DHPS, QDPR, SPR | CYP3A4 608/4885TDP1 4637/4885TAAR1 4102/4885 |
| US-20070141684-A1 | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein | SCN2A, CACNG2, SCN1A | CYP3A4 4080/4885TDP1 4202/4885TAAR1 2517/4885 |
| US-11819837-B2 | Monocarbonyl ruthenium and osmium catalysts | OTC, CBR3, IDH2 | CYP3A4 2612/4885TDP1 3573/4885TAAR1 663/4885 |
| US-20020058832-A1 | Novel olefination process to itaconate and succinate derivatives | HOGA1, HADHA, OGDH | CYP3A4 219/4885TDP1 3344/4885TAAR1 4617/4885 |
| US-20090299093-A1 | Preparation of Gamma-Amino Acids Having Affinity for The Alpha-2-Delta Protein | SCN2A, CACNG2, SCN1A | CYP3A4 4080/4885TDP1 4202/4885TAAR1 2517/4885 |
| US-11278876-B2 | Monocarbonyl ruthenium and osmium catalysts | OTC, CBR3, IDH2 | CYP3A4 2612/4885TDP1 3573/4885TAAR1 663/4885 |
| US-20200317659-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | DHPS, QDPR, SPR | CYP3A4 608/4885TDP1 4637/4885TAAR1 4102/4885 |
| US-20150274650-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE NEP INHIBITORS | MME, DNPEP, REN | CYP3A4 370/4885TDP1 1469/4885TAAR1 1302/4885 |
| US-20040010139-A1 | Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams | MRPL21, LAS1L, OXA1L | CYP3A4 2432/4885TDP1 4793/4885TAAR1 4744/4885 |
| US-12129249-B2 | Method for producing optically active compound | DHPS, QDPR, SPR | CYP3A4 608/4885TDP1 4637/4885TAAR1 4102/4885 |
| US-20140243546-A1 | Processes | MME, NAT1, AGTR1 | CYP3A4 528/4885TDP1 1039/4885TAAR1 265/4885 |
| US-20090247743-A1 | PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | SCN2A, SCN1A, ORAI2 | CYP3A4 4159/4885TDP1 4201/4885TAAR1 2421/4885 |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | PAH, SPR, IL4I1 | CYP3A4 58/4885TDP1 4266/4885TAAR1 1417/4885 |
| US-20220168720-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, CBR3, IDH2 | CYP3A4 2612/4885TDP1 3573/4885TAAR1 663/4885 |
| US-20120142934-A1 | METHOD FOR SYNTHESIS OF SECONDARY ALCOHOLS | ADH1A, ADH1C, ADH5 | CYP3A4 92/4885TDP1 4102/4885TAAR1 482/4885 |
| US-20150246881-A1 | Processes | MME, NAT1, AGTR1 | CYP3A4 528/4885TDP1 1039/4885TAAR1 265/4885 |
| US-20080194841-A1 | Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein | OPRD1, CHRND, CHRNE | CYP3A4 4026/4885TDP1 4001/4885TAAR1 1198/4885 |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, ODC1, CBR3 | CYP3A4 2997/4885TDP1 908/4885TAAR1 1056/4885 |
| US-20210347769-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | DHPS, QDPR, SPR | CYP3A4 608/4885TDP1 4637/4885TAAR1 4102/4885 |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | OTC, CBR3, IDH2 | CYP3A4 2612/4885TDP1 3573/4885TAAR1 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.